Multiple cutaneous and mucosal venous malformations
Also known as VMCM, cutaneous and mucosal venous malformation, VENOUS malformations, multiple cutaneous and mucosal, Vmcm1+1 more
VMCM, cutaneous and mucosal venous malformation, VENOUS malformations, multiple cutaneous and mucosal, Vmcm1, mucocutaneous venous malformations.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 3 clinical trials expected to report results, the earliest in Q4 2026.
- Q4 2026Comparative Study Between Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique
- Q4 2027Systematic Management Approach for Children and Adolescents With Orbital Lymphatic Malformation
- Q3 2030Efficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Controlled Clinical Trial
Clinical MilestonesViewHide
- 2026-07-01Comparative Study Between Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS TechniqueResults expected Q4 2026
- 2026-03-19Efficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Controlled Clinical TrialResults expected Q3 2030
- 2026-01-30Systematic Management Approach for Children and Adolescents With Orbital Lymphatic MalformationResults expected Q4 2027
- 2026-04-01Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.Completed
- 2025-11-21A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous MalformationsPrimary completion
- 2026-07-01ClinicalComparative Study Between Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS TechniqueResults expected Q4 2026
- 2026-04-01ClinicalEvaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ.Completed
- 2026-03-19ClinicalEfficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Controlled Clinical TrialResults expected Q3 2030
- 2026-01-30ClinicalSystematic Management Approach for Children and Adolescents With Orbital Lymphatic MalformationResults expected Q4 2027
- 2025-11-21ClinicalA Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous MalformationsPrimary completion
Clinical trials
The current development programme across all trial phases.
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
VMCM, cutaneous and mucosal venous malformation, VENOUS malformations, multiple cutaneous and mucosal, Vmcm1, mucocutaneous venous malformations
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Related entities are derived from literature co-mention (studied together) — associative, not causal.